[144] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filing for proposed sale of $908,894.51 in common stock (51,379 shares) with an approximate sale date of 10/09/2025. The shares were acquired as Restricted Stock Units on 10/04/2025 and show 51,379 units to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The filing lists 198,031,417 shares outstanding, and records prior 10b5-1 sales by the same account totaling 62,000 shares during August 2025 for aggregate gross proceeds of $946,833.62 across three trades. Certain standard issuer identification fields (issuer name and SEC file number) are not populated in the visible text, so the filing cannot be tied to an issuer by name from this extract.

Positive

• Planned sale is disclosed publicly, supporting regulatory transparency
• Broker listed (Morgan Stanley Smith Barney LLC), indicating institutional execution

Negative

• Issuer name and SEC file number are not provided in the visible extract, limiting issuer identification
• Large insider sales year-to-date (62,000 shares sold in August 2025 plus 51,379 proposed) which may increase share supply

Insights

Equity Compensation Analyst

Insider plans to sell recently vested RSUs and has executed prior 10b5-1 sales this year.

The filing documents a proposed sale of 51,379 common shares acquired as Restricted Stock Units on 10/04/2025, with an expected sale value of $908,894.51 on 10/09/2025. Sales are routed through Morgan Stanley Smith Barney LLC on NASDAQ, indicating use of an institutional broker for an orderly disposition.

Prior 10b5-1 executions show systematic selling in August 2025 totaling 62,000 shares and gross proceeds of $946,833.62, which suggests continued vesting-driven or plan-driven liquidity rather than an isolated trade. Monitor the completion date 10/09/2025 and any subsequent filings for cumulative insider sales against outstanding share count of 198,031,417.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	51379	908894.51	198031417	10/09/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/04/2025	Restricted Stock Units	Issuer			51379	10/04/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for HYONG J KIM 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	08/22/2025	24800	396800.00
10b5-1 Sales for HYONG J KIM 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	08/13/2025	18600	279608.22
10b5-1 Sales for HYONG J KIM 1100 W. Town and Country Road Suite 1600 Orange CA 92868	Common	08/11/2025	18600	270425.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for ALHC show about the proposed sale?

The form shows a proposed sale of 51,379 common shares valued at $908,894.51, with an approximate sale date of 10/09/2025 via NASDAQ.

How were the shares being sold acquired?

The shares were acquired as Restricted Stock Units (RSUs) on 10/04/2025, with the same date listed for acquisition and payment.

Has the filer sold shares recently?

Yes. The filing records three 10b5-1 sales in August 2025 totaling 62,000 shares for aggregate gross proceeds of $946,833.62.

How many shares does the company have outstanding according to the filing?

The filing lists 198,031,417 shares outstanding.

Who is the broker handling the proposed sale?

The broker is listed as Morgan Stanley Smith Barney LLC Executive Financial Services located at 1 New York Plaza, New York, NY.